Mentice Introduces TACE Simulation Training Solution

 

September 6, 2017—Mentice, a provider of endovascular simulation solutions, announced the release of a new simulation training software for transarterial chemoembolization (TACE).

The company noted that TACE is a challenging procedure that involves various subtechniques, complex anatomies, and variant vasculatures requiring the extensive use of radiation. Success of the procedure and the impact on cost is tied to the ability to complete it safely and accurately within the permitted radiation doses. Mentice's TACE simulation training solution aims to reduce TACE procedure times and minimize radiation.

According to the company, the TACE training solution is based on real-life cases and features an integrated radiation safety module that monitors doses for patients and staff at all times. The software also provides output of metrics, enabling an objective assessment of trainees’ progress.

Mentice stated that the new software will be showcased at the CIRSE 2017 annual congress to be held September 16–20 in Copenhagen, Denmark. During CIRSE, the software will be available for testing and demonstrations at the company's booth and at "The Basics of Chemoembolization for the Liver" session being held as part of the "Principles to Practice: Education and Simulation Skills Training" program.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.